Revised: 31 May 2019

Medicines

 

Medsafe Product Detail

File ref: TT50-6869/1
Trade NameDose FormStrengthIdentifier
Pam's Paracetamol TabletsTablet500 mgcapsule shaped
SponsorApplication dateRegistration situationClassification
REX Medical Ltd
P O Box 18119
Glen Innes
AUCKLAND 1743
15/3/2002Consent given
Approval date: 14/11/2002
General sale
 

Composition

ComponentIngredientManufacturer
tabletActive 
 Paracetamol 500mgFarmson Pharmaceutical Gujarat Pvt Ltd
(Unit I), 28-35, GIDC
Nandesari
District Vadodara
Gujarat 391340
INDIA
  Granules India Limited
8-3-1066, Plot No. 11
Sringar Colony
Hyderabad 500 873
INDIA
  SpecGx LLC
8801 Capital Boulevard
Raleigh
North Carolina 27616-3116
UNITED STATES OF AMERICA
 Excipient 
 Hydrated silica
 Magnesium stearate
 Maize starch
 Povidone
 Purified talc
 Sodium laurilsulfate
 Sodium metabisulfite
 Sodium starch glycolate

Production

Manufacturing stepManufacturer
Finished Product TestingSharon Bio-Medicine Limited
Central Hope Town
Selaqui Industrial Area
Dehradun
Uttarakhand IN-248 001
INDIA
Manufacture of Final Dose FormCipla Ltd
Manufacturing Division
Plot No. A-33/1/2
Patalganga Industrial Area
District Raigad, (Maharashtra) 410 220
INDIA
 Cipla Ltd
Manufacturing Division
Plot No. D-7, MIDC Industrial Area
Kurkumbh Village, Taluka - Daund
District - Pune, Maharashtra State 413 802
INDIA
 Sharon Bio-Medicine Limited
Central Hope Town
Selaqui Industrial Area
Dehradun
Uttarakhand IN-248 001
INDIA
PackingCipla Ltd
Manufacturing Division
Plot No. A-33/1/2
Patalganga Industrial Area
District Raigad, (Maharashtra) 410 220
INDIA
 Cipla Ltd
Manufacturing Division
Plot No. D-7, MIDC Industrial Area
Kurkumbh Village, Taluka - Daund
District - Pune, Maharashtra State 413 802
INDIA
 Sharon Bio-Medicine Limited
Central Hope Town
Selaqui Industrial Area
Dehradun
Uttarakhand IN-248 001
INDIA
NZ Site of Product ReleaseNo site specified

Packaging

PackageContentsShelf Life
Blister pack, PVC/Aluminium - 20 tablets20 tablets36 months from date of manufacture stored at or below 30°C

Indications

Latest Regulatory Activity

Application DateApplication TypeChange(s)StatusPayment DatePriority
18/3/2024Self-Assessable Change NotificationActive ingredient specifications/test methods - G1 (Self assessable)Notified25/3/2024 
Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /